ZPD A/S: Financial statements 2023
CVR: 32834825
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ZPD A/S (CVR 32834825) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 43,788,000 and a net result of DKK 11,824,000 compared with DKK 7,067,000 the year before. That is an increase of 17.5% compared with the year before. Equity in the 2023 report amounted to DKK 197,056,000. The solvency ratio was 94.2%. The company had 35 employees in the financial year.
- Gross Profit
- DKK 43,788,000
- Profit/Loss
- DKK 11,824,000
- Equity
- DKK 197,056,000
- Total Assets
- DKK 209,257,000
- Employees
- 35
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 43.8 mio. | 11.8 mio. | 197.1 mio. | 35 |
| 2022 | - | 37.3 mio. | 7.1 mio. | 185.2 mio. | 35 |
| 2021 | - | 35.2 mio. | 7 mio. | 178.2 mio. | 36 |
| 2020 | - | 35.6 mio. | 6 mio. | 171.2 mio. | 34 |
| 2019 | - | 36.8 mio. | 7.7 mio. | 165.2 mio. | 33 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of April 1, 2023, Masakazu Sakurai has joined the board of directors of ZPD A/S.
As of April 1, 2023, Kenichi Suzuki has left the board of directors of ZPD A/S.
ZPD A/S has published its annual report for 2022. Gross profit came to DKK 37,256,000, and the net result was DKK 7,067,000.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.